CimaVax was developed by government-run Molecular Immunology Center. It's not brand new, and Cuba has not kept its success a secret. Cuban researchers were testing the drug in the 1990s and major world media outlets have reported on it in the 2000s.
The center has also developed a second lung cancer drug called Racotumomab, which encourages the immune system to fight solid tumors.
There’s also potential for importing Cuban medicines treating other conditions.
One drug Heberprot-P helps treat diabetic foot ulcers. It’s used in 18 countries, and is undergoing trial in the European Union, but the embargo has kept it out of the US.
Cuba approves, makes available lung cancer vaccine | Reuters
Lung cancer vaccine 'extends terminal patients lives' - CNN.com
Officials at the Roswell Park Cancer Institute say they’ve penned a deal to that could lead to cancer breakthroughs in the U.S. thanks to a recent trip to Cuba with Governor Andrew Cuomo.
Cuomo was the first American Governor to visit the country since the president eased sanctions with the island nation.
Roswell Park Cancer Institute CEO and President, Dr. Candace Johnson told News 4 that the two-day event was very productive.
“There were a lot of people from different sectors there and I think everyone found it very encouraging. I think New York should be proud because we were the first state to go to Cuba,” Dr. Johnson said.
Due to the trip, Roswell Park now has a partnership with the Cuban Center for Molecular Immunology.
Johnson said they have a vaccine for lung cancer. She wants to do clinical trials on it in the U.S. to see if it can be administered to patients. For example, if someone has the early stages of lung cancer and has surgery to remove a nodule, Dr. Johnson said if the vaccine is approved, it may be able to help them.
“Those patients have a very high risk for reoccurrence. You have one nodule, you’ll maybe get another nodule. You could take perhaps this vaccine that could help prevent a reoccurrence,” she said.
First, Roswell needs FDA approval to start the trial.
Johnson believes it may not only prevent lung cancer growth, but the growth of other cancers as well.
“The growth factor causes it to grow. If you take the growth factor away, the cancer doesn’t grow. So this is an anti-growth factor vaccine,” Dr. Johnson said. “That’s unique. It’s not killing the tumor cell directly, It’s taking something the tumor cell needs to grow away. So it has less toxicity associated with it.”
Johnson says the Cuban Center has other vaccine’s that they’re interested in.
She adds that officials from the island nation will be traveling to Buffalo in the future to work on this new partnership.
Roswell Park Cancer Institute pens deal with Cuban center | wivb.com
The center has also developed a second lung cancer drug called Racotumomab, which encourages the immune system to fight solid tumors.
There’s also potential for importing Cuban medicines treating other conditions.
One drug Heberprot-P helps treat diabetic foot ulcers. It’s used in 18 countries, and is undergoing trial in the European Union, but the embargo has kept it out of the US.
Cuba approves, makes available lung cancer vaccine | Reuters
Lung cancer vaccine 'extends terminal patients lives' - CNN.com
Officials at the Roswell Park Cancer Institute say they’ve penned a deal to that could lead to cancer breakthroughs in the U.S. thanks to a recent trip to Cuba with Governor Andrew Cuomo.
Cuomo was the first American Governor to visit the country since the president eased sanctions with the island nation.
Roswell Park Cancer Institute CEO and President, Dr. Candace Johnson told News 4 that the two-day event was very productive.
“There were a lot of people from different sectors there and I think everyone found it very encouraging. I think New York should be proud because we were the first state to go to Cuba,” Dr. Johnson said.
Due to the trip, Roswell Park now has a partnership with the Cuban Center for Molecular Immunology.
Johnson said they have a vaccine for lung cancer. She wants to do clinical trials on it in the U.S. to see if it can be administered to patients. For example, if someone has the early stages of lung cancer and has surgery to remove a nodule, Dr. Johnson said if the vaccine is approved, it may be able to help them.
“Those patients have a very high risk for reoccurrence. You have one nodule, you’ll maybe get another nodule. You could take perhaps this vaccine that could help prevent a reoccurrence,” she said.
First, Roswell needs FDA approval to start the trial.
Johnson believes it may not only prevent lung cancer growth, but the growth of other cancers as well.
“The growth factor causes it to grow. If you take the growth factor away, the cancer doesn’t grow. So this is an anti-growth factor vaccine,” Dr. Johnson said. “That’s unique. It’s not killing the tumor cell directly, It’s taking something the tumor cell needs to grow away. So it has less toxicity associated with it.”
Johnson says the Cuban Center has other vaccine’s that they’re interested in.
She adds that officials from the island nation will be traveling to Buffalo in the future to work on this new partnership.
Roswell Park Cancer Institute pens deal with Cuban center | wivb.com
